Profilo
Nikolai Søren Kirkby is the founder of Nordic Vaccine A, which was founded in 2001.
He held the title of Chief Scientific Officer from 2009 to 2012.
Dr. Kirkby's former job was as a Principal at the University of Copenhagen.
He received a graduate degree from the University of Copenhagen in 1992 and a doctorate degree in 1995.
Precedenti posizioni note di Nikolai Søren Kirkby
| Società | Posizione | Fine |
|---|---|---|
| University of Copenhagen | Corporate Officer/Principal | - |
Nordic Vaccine A/S
 Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Fondatore | - |
Formazione di Nikolai Søren Kirkby
| University of Copenhagen | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Nordic Vaccine A/S
Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Nikolai Søren Kirkby
